WORKING GROUP NAME: PATIENT PREFERENCES TO VALUE HEALTH OUTCOMES IN RHEUMATOLOGY CLINICAL TRIALS (PPRCTs)

Researchers, patients, clinicians and policy-makers need to make certain trade-offs when making treatment decisions. These trade-offs include treatment safety, cost, duration, and effectiveness. Understanding patient preferences for these trade-offs is critical to making sure that the evidence we generate and use is relevant for the patients and physicians who have to make these choices every day. Our work will provide foundational knowledge regarding the most appropriate and feasible methods researchers can use to measure patient preferences to inform clinical trial design and interpretation

OMERACT 2020 Virtual Session Agenda

Screen Shot 2020-09-26 at 10.36.11 AM

CLICK BELOW FOR VIRTUAL SESSION MATERIALS

CO-CHAIRS

Screen Shot 2020-09-26 at 10.57.09 AM

Nick Bansback:

nick.bansback@ubc.ca

Screen Shot 2020-09-18 at 11.26.01 AM

Annelies Boonen:

a.boonen@mumc.nl

Screen Shot 2020-09-26 at 10.57.36 AM

Rachelle Buchbinder:

rachelle.buchbinder@monash.edu

Screen Shot 2020-09-26 at 10.58.31 AM

Liana Fraenkel:

liana.fraenkel@yale.edu

Screen Shot 2020-09-26 at 10.59.11 AM

Glen Hazelwood:

glenhazlewood@gmail.com

FELLOW

Screen Shot 2020-09-26 at 11.10.21 AM

Megan Thomas

PRP

Screen Shot 2020-09-26 at 11.07.47 AM

Laurie Proulx

PRP's

Screen Shot 2020-09-22 at 7.54.05 PM

Pam Richards

PRP

Screen Shot 2020-09-25 at 11.26.21 AM

Marieke Scholte-Voshaar

MEMBERSHIP:

Glean Hazelwood
Nick Bansback
Liana Fraenkel

Annelies Boonen
Rachelle Buchbinder
Megan Thomas
Peter Tugwell

Francis Guillemin
Mickael Hiligsmann
Deborah Marshall